Anaphylaxis to beta-lactam antibiotics at pediatric age: Six-year survey.


Journal

Allergologia et immunopathologia
ISSN: 1578-1267
Titre abrégé: Allergol Immunopathol (Madr)
Pays: Singapore
ID NLM: 0370073

Informations de publication

Date de publication:
Historique:
received: 28 01 2018
revised: 28 06 2018
accepted: 03 07 2018
pubmed: 27 9 2018
medline: 27 6 2019
entrez: 26 9 2018
Statut: ppublish

Résumé

Beta-lactams are the most frequently used antibiotics in pediatric age. Anaphylactic reactions may occur and need to be properly studied, but studies in children are scarce. Characterization of case reports of anaphylaxis in children referred to an allergy department with suspected beta-lactams hypersensitivity. Retrospective analysis of all children referred to our Drug Allergy Center with suspected beta-lactams hypersensitivity between January 2011 and December 2016. Description of the drug allergy work-up performed studied according to standardized diagnostic procedures of ENDA/EAACI, including specific-IgE assay, skin prick and intradermal tests and diagnostic/alternative drug challenge tests. 146 children with suspected beta-lactams hypersensitivity were studied, and in 21 (14.4%) the diagnosis was confirmed. In all of them, except for three children, an alternative beta-lactam was found. In seven children (33.3% of those with confirmed beta-lactams hypersensitivity) anaphylaxis was confirmed, and all of them described reactions with cutaneous and respiratory or gastrointestinal involvement. The culprit drug was amoxicillin in six and flucloxacillin in one. In this sample, we also performed oral challenge with cefuroxime, being negative in all cases. Almost all cases of confirmed anaphylaxis (six from seven cases) were IgE mediated, with positive skin tests despite negative serum specific-IgE. Allergic reactions to beta-lactams, although rare in children, require a detailed clinical history and a specialized drug allergy work-up to allow a correct diagnosis as well as to avoid the possibility of a potential life-threatening reaction and provide alternative drugs.

Identifiants

pubmed: 30249451
pii: S0301-0546(18)30114-9
doi: 10.1016/j.aller.2018.07.008
pii:
doi:

Substances chimiques

Allergens 0
beta-Lactams 0
Immunoglobulin E 37341-29-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

128-132

Informations de copyright

Copyright © 2018 SEICAP. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

J Azevedo (J)

Immunoallergy Department, Coimbra Hospital Universitary Centre, Coimbra, Portugal.

 Gaspar (Â)

Immunoallergy Department, CUF Descobertas Hospital, Lisbon, Portugal. Electronic address: angela.gaspar@sapo.pt.

I Mota (I)

Immunoallergy Department, CUF Descobertas Hospital, Lisbon, Portugal.

F Benito-Garcia (F)

Immunoallergy Department, CUF Descobertas Hospital, Lisbon, Portugal.

M Alves-Correia (M)

Immunoallergy Department, CUF Descobertas Hospital, Lisbon, Portugal.

M Chambel (M)

Immunoallergy Department, CUF Descobertas Hospital, Lisbon, Portugal.

M Morais-Almeida (M)

Immunoallergy Department, CUF Descobertas Hospital, Lisbon, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH